Xie X - Search Results

1

Turning up a new pattern: Identification of cancer-associated fibroblast-related clusters in TNBC.

Xie J, Zheng S, Zou Y, Tang Y, Tian W, Wong CW, Wu S, Ou X, Zhao W, Cai M, Xie X. Xie J, et al. Among authors: xie x. Front Immunol. 2022 Oct 6;13:1022147. doi: 10.3389/fimmu.2022.1022147. eCollection 2022. Front Immunol. 2022. PMID: 36275659 Free PMC article.

2

Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: a meta-analysis.

Wang J, Xie X, Wang X, Tang J, Pan Q, Zhang Y, Di M. Wang J, et al. Among authors: xie x. Surg Oncol. 2013 Dec;22(4):247-55. doi: 10.1016/j.suronc.2013.10.001. Epub 2013 Oct 12. Surg Oncol. 2013. PMID: 24144808 Review.

3

Up-regulation and worse prognostic marker of cytoplasmic TARBP2 expression in obstinate breast cancer.

Lin X, Wu M, Liu P, Wei F, Li L, Tang H, Xie X, Liu X, Yang L, Xie X. Lin X, et al. Among authors: xie x. Med Oncol. 2014 Apr;31(4):868. doi: 10.1007/s12032-014-0868-9. Epub 2014 Feb 22. Med Oncol. 2014. PMID: 24563327

4

miR-185 suppresses tumor proliferation by directly targeting E2F6 and DNMT1 and indirectly upregulating BRCA1 in triple-negative breast cancer.

Tang H, Liu P, Yang L, Xie X, Ye F, Wu M, Liu X, Chen B, Zhang L, Xie X. Tang H, et al. Among authors: xie x. Mol Cancer Ther. 2014 Dec;13(12):3185-97. doi: 10.1158/1535-7163.MCT-14-0243. Epub 2014 Oct 15. Mol Cancer Ther. 2014. PMID: 25319390

5

ERβ1 inversely correlates with PTEN/PI3K/AKT pathway and predicts a favorable prognosis in triple-negative breast cancer.

Wang J, Zhang C, Chen K, Tang H, Tang J, Song C, Xie X. Wang J, et al. Among authors: xie x. Breast Cancer Res Treat. 2015 Jul;152(2):255-69. doi: 10.1007/s10549-015-3467-3. Epub 2015 Jun 13. Breast Cancer Res Treat. 2015. PMID: 26070269

6

Development and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancer.

Wen J, Ye F, He X, Li S, Huang X, Xiao X, Xie X. Wen J, et al. Among authors: xie x. Oncotarget. 2016 Apr 12;7(15):21046-53. doi: 10.18632/oncotarget.8091. Oncotarget. 2016. PMID: 26992235 Free PMC article. Clinical Trial.

7

mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK.

Liu P, Ye F, Xie X, Li X, Tang H, Li S, Huang X, Song C, Wei W, Xie X. Liu P, et al. Among authors: xie x. Oncotarget. 2016 Jun 7;7(23):35188-98. doi: 10.18632/oncotarget.9072. Oncotarget. 2016. PMID: 27145268 Free PMC article.

8

Nomograms for Predicting the Prognostic Value of Pre-Therapeutic CA15-3 and CEA Serum Levels in TNBC Patients.

Dai D, Chen B, Tang H, Wang B, Zhao Z, Xie X, Wei W. Dai D, et al. Among authors: xie x. PLoS One. 2016 Aug 25;11(8):e0161902. doi: 10.1371/journal.pone.0161902. eCollection 2016. PLoS One. 2016. PMID: 27561099 Free PMC article.

9

High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer.

Huang X, Li X, Xie X, Ye F, Chen B, Song C, Tang H, Xie X. Huang X, et al. Among authors: xie x. Breast. 2016 Dec;30:39-46. doi: 10.1016/j.breast.2016.08.014. Epub 2016 Sep 4. Breast. 2016. PMID: 27598996

10

Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer.

Chen B, Dai D, Tang H, Ai X, Chen X, Zhang X, Li Z, Xie X. Chen B, et al. Among authors: xie x. PLoS One. 2016 Nov 16;11(11):e0165133. doi: 10.1371/journal.pone.0165133. eCollection 2016. PLoS One. 2016. PMID: 27851755 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,714 results

Search Page

Filters